Resistance to anticoagulant activity of annexin A5 in patients with antiphospholipid syndrome with and without systemic lupus erythematosus receiving hydroxychloroquine

被引:0
|
作者
Breen, K. A. [1 ]
Wu, X. [2 ]
Rand, J. H. [2 ]
Hunt, B. J. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Montefiore Med Ctr, New York, NY USA
关键词
THROMBOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:598 / 598
页数:1
相关论文
共 50 条
  • [41] Antiphospholipid syndrome: Cohort of Tunisian patients with systemic lupus erythematosus
    Hammami, S.
    Chebbi, W.
    Aloui, S.
    Boumiza, R.
    Hamzaoui, A.
    Hassine, M.
    ElMay, M.
    Mahjoub, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 128 - 128
  • [42] Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Reshetnyak, Tatiana
    Nurbaeva, Kamila
    Ptashnik, Ivan
    Kudriaeva, Anna
    Belogurov Jr, Alexey
    Lila, Aleksandr
    Nasonov, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [43] FXIII levels in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Bagoly, Z.
    Toth, N. K.
    Tarr, T.
    Soltesz, P.
    Katona, E.
    Mezei, Z. A.
    Muszbek, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S416 - S417
  • [44] Inadequate Screening for Antiphospholipid Syndrome with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
    Munawar, Tooba
    Sherazi, Mahnoor
    Perl, Andras
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1810 - 1811
  • [45] SKIN LESIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME
    Shumilova, A.
    Cheldieva, F.
    Reshetnyak, T.
    Lila, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 643 - 644
  • [46] Stroke in patients with systemic lupus erythematosus and antiphospholipid antibody syndrome
    Chaves C.J.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (3) : 223 - 229
  • [47] Administration of vasaprostan in patients with systemic lupus erythematosus with antiphospholipid syndrome
    Reshetnyak, TM
    Alekberova, ZS
    Nasonova, VA
    TERAPEVTICHESKII ARKHIV, 1999, 71 (05) : 40 - 47
  • [48] Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
    Baalbaki, Sima
    Szychowski, Jeff M.
    Tang, Ying
    Wetta, Luisa
    Subramaniam, Akila
    OCHSNER JOURNAL, 2020, 20 (04): : 362 - 367
  • [49] ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH LUPUS ANTICOAGULANT WITHOUT SYSTEMIC LUPUS-ERYTHEMATOSUS
    ORDI, J
    BARQUINERO, J
    MONTALBAN, J
    SELVA, A
    VILARDELL, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1988, 6 (02) : 198 - 198
  • [50] Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients
    Michelle Petri
    Current Rheumatology Reports, 2011, 13 : 77 - 80